Structural basis for motilin and erythromycin recognition by motilin receptor

Motilin is an endogenous peptide hormone almost exclusively expressed in the human gastrointestinal (GI) tract. It activates the motilin receptor (MTLR), a class A G protein–coupled receptor (GPCR), and stimulates GI motility. To our knowledge, MTLR is the first GPCR reported to be activated by macrolide antibiotics, such as erythromycin. It has attracted extensive attention as a potential drug target for GI disorders. We report two structures of Gq-coupled human MTLR bound to motilin and erythromycin. Our structures reveal the recognition mechanism of both ligands and explain the specificity of motilin and ghrelin, a related gut peptide hormone, for their respective receptors. These structures also provide the basis for understanding the different recognition modes of erythromycin by MTLR and ribosome. These findings provide a framework for understanding the physiological regulation of MTLR and guiding drug design targeting MTLR for the treatment of GI motility disorders.

[1]  Yi Jiang,et al.  Structural insights into the peptide selectivity and activation of human neuromedin U receptors , 2022, Nature Communications.

[2]  G. Sanger.  Why is motilin active in some studies with mice, rats, and guinea pigs, but not in others? Implications for functional variability among rodents , 2022, Pharmacology research & perspectives.

[3]  Hualiang Jiang,et al.  Molecular basis for allosteric agonism and G protein subtype selectivity of galanin receptors , 2022, Nature Communications.

[4]  H. Kaiya,et al.  Motilin Comparative Study: Structure, Distribution, Receptors, and Gastrointestinal Motility , 2021, Frontiers in Endocrinology.

[5]  J. Carazo,et al.  DeepEMhancer: a deep learning solution for cryo-EM volume post-processing , 2021, Communications Biology.

[6]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[7]  Xinheng He,et al.  Molecular recognition of an acyl-peptide hormone and activation of ghrelin receptor , 2021, Nature Communications.

[8]  H. Xu,et al.  Molecular basis for kinin selectivity and activation of the human bradykinin receptors , 2021, Nature Structural & Molecular Biology.

[9]  S. Iwata,et al.  Structure of an antagonist-bound ghrelin receptor reveals possible ghrelin recognition mode , 2020, Nature Communications.

[10]  Xinheng He,et al.  Cryo-EM structure of an activated VIP1 receptor-G protein complex revealed by a NanoBiT tethering strategy , 2020, Nature Communications.

[11]  Coulibaly Songuigama,et al.  Pharmacochemical Aspects of the Evolution from Erythromycin to Neomacrolides, Ketolides and Neoketolides , 2020 .

[12]  S. Cantel,et al.  Structure and dynamics of G protein-coupled receptor–bound ghrelin reveal the critical role of the octanoyl chain , 2019, Proceedings of the National Academy of Sciences.

[13]  J. Tack,et al.  Motilin: from gastric motility stimulation to hunger signalling , 2019, Nature Reviews Endocrinology.

[14]  G. Skiniotis,et al.  Development of an antibody fragment that stabilizes GPCR/G-protein complexes , 2018, Nature Communications.

[15]  W. Weis,et al.  The Molecular Basis of G Protein-Coupled Receptor Activation. , 2018, Annual review of biochemistry.

[16]  Tristan Ian Croll,et al.  ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps , 2018, Acta crystallographica. Section D, Structural biology.

[17]  J. Tack,et al.  The motilin agonist erythromycin increases hunger by modulating homeostatic and hedonic brain circuits in healthy women: a randomized, placebo-controlled study , 2018, Scientific Reports.

[18]  O. O'Daly,et al.  The motilin agonist erythromycin increases hunger by modulating homeostatic and hedonic brain circuits in healthy women: a randomized, placebo-controlled study , 2018, Scientific Reports.

[19]  C. Tate,et al.  Mini-G proteins: Novel tools for studying GPCRs in their active conformation , 2017, PloS one.

[20]  D. Agard,et al.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.

[21]  Rafael Fernandez-Leiro,et al.  A pipeline approach to single-particle processing in RELION , 2016, bioRxiv.

[22]  G. Sanger,et al.  RQ-00201894: A motilin receptor agonist causing long-lasting facilitation of human gastric cholinergically-mediated contractions. , 2016, Journal of pharmacological sciences.

[23]  G. Sanger,et al.  Ghrelin and motilin receptors as drug targets for gastrointestinal disorders , 2016, Nature Reviews Gastroenterology &Hepatology.

[24]  N. Grigorieff,et al.  CTFFIND4: Fast and accurate defocus estimation from electron micrographs , 2015, bioRxiv.

[25]  G. Sanger,et al.  Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists , 2013, British journal of pharmacology.

[26]  G. Sanger,et al.  The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin , 2013, British journal of pharmacology.

[27]  G. Sanger,et al.  Regional‐ and agonist‐dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists , 2012, British journal of pharmacology.

[28]  Y. Hiasa,et al.  A relationship between motilin and growth hormone secretagogue receptors , 2012, Regulatory Peptides.

[29]  M. Morar,et al.  Mechanism and diversity of the erythromycin esterase family of enzymes. , 2012, Biochemistry.

[30]  Ya-ping Zhang,et al.  Stepwise loss of motilin and its specific receptor genes in rodents. , 2010, Journal of molecular endocrinology.

[31]  H. Parkman,et al.  Effect of Atilmotin, a Motilin Receptor Agonist, on Esophageal, Lower Esophageal Sphincter, and Gastric Pressures , 2010, Digestive Diseases and Sciences.

[32]  I. Sandlie,et al.  Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding* , 2009, The Journal of Biological Chemistry.

[33]  O. Cynshi,et al.  Motilides: A long and winding road Lessons from mitemcinal (GM-611) on diabetic gastroparesis , 2009, Regulatory Peptides.

[34]  Erik Näslund,et al.  GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility , 2009 .

[35]  A. Muir,et al.  GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility. , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[36]  P. Vanden Berghe,et al.  Differences in motilin receptor desensitization after stimulation with motilin or motilides are due to alternative receptor trafficking. , 2008, Biochemical pharmacology.

[37]  G. Sanger,et al.  Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro , 2007, British journal of pharmacology.

[38]  I. Depoortere,et al.  Delineation of the motilin domain involved in desensitization and internalization of the motilin receptor by using full and partial antagonists. , 2007, Biochemical pharmacology.

[39]  A. Zinsmeister,et al.  Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo‐controlled study , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[40]  R. Seethala,et al.  Characterization of Agonist-Induced Motilin Receptor Trafficking and Its Implications for Tachyphylaxis , 2006, Molecular Pharmacology.

[41]  I. Depoortere,et al.  Motilin and erythromycin-A share a common binding site in the third transmembrane segment of the motilin receptor , 2005 .

[42]  William A Craig,et al.  The importance of bactericidal drugs: future directions in infectious disease. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  Randy J Read,et al.  Recent developments in the PHENIX software for automated crystallographic structure determination. , 2004, Journal of synchrotron radiation.

[44]  S. Zotchev,et al.  Biosynthesis of deoxyaminosugars in antibiotic-producing bacteria , 2004, Applied Microbiology and Biotechnology.

[45]  L. Miller,et al.  Differential Determinants for Peptide and Non-peptidyl Ligand Binding to the Motilin Receptor , 2002, The Journal of Biological Chemistry.

[46]  F. Schluenzen,et al.  Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.

[47]  Jilly F. Evans,et al.  Receptor for motilin identified in the human gastrointestinal system. , 1999, Science.

[48]  Z. Itoh.  Motilin and Clinical Application , 1997, Peptides.

[49]  Roy G. Smith,et al.  Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. , 1997, Genomics.

[50]  A. Andriulli,et al.  Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin‐dependent) diabetes mellitus , 1997, Alimentary pharmacology & therapeutics.

[51]  R. McCallum,et al.  Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. , 1993, The American journal of gastroenterology.

[52]  X. Z. Shi,et al.  [Erythromycin: a motilin receptor agonist]. , 1992, Sheng li ke xue jin zhan [Progress in physiology].

[53]  J. Hoogmartens,et al.  Structure‐Activity Relation of Erythromycin‐Related Macrolides in Inducing Contractions and in Displacing Bound Motilin in Rabbit Duodenum , 1989 .

[54]  S. Ōmura,et al.  Motilides, macrolides with gastrointestinal motor stimulating activity. I. O-substituted and tertiary N-substituted derivatives of 8,9-anhydroerythromycin A 6,9-hemiacetal. , 1989, Chemical & pharmaceutical bulletin.

[55]  J. Hoogmartens,et al.  Erythromycin is a motilin receptor agonist. , 1989, The American journal of physiology.

[56]  S. Ōmura,et al.  Erythromycin and its derivatives with motilin-like biological activities inhibit the specific binding of 125I-motilin to duodenal muscle. , 1988, Biochemical and biophysical research communications.

[57]  W. Summer,et al.  Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung. , 1987, The American review of respiratory disease.

[58]  K. Wakabayashi,et al.  Structure-activity relation among macrolide antibiotics in initiation of interdigestive migrating contractions in the canine gastrointestinal tract. , 1985, The American journal of physiology.

[59]  K. Wakabayashi,et al.  Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. , 1984, The American journal of physiology.

[60]  J. Brown,et al.  The further purification of motilin, a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs. , 1971, Canadian journal of physiology and pharmacology.

[61]  M. Finland,et al.  The Antibacterial Action of Erythromycin.∗ , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[62]  J. W. Smith,et al.  [Ilotycin, a new antibiotic]. , 1952, Schweizerische medizinische Wochenschrift.